140 related articles for article (PubMed ID: 2421395)
1. Biological studies of schizophrenia in Europe.
Prilipko LL
Schizophr Bull; 1986; 12(1):83-100. PubMed ID: 2421395
[TBL] [Abstract][Full Text] [Related]
2. Neurotransmitters and CNS disease. Schizophrenia.
Snyder SH
Lancet; 1982 Oct; 2(8305):970-4. PubMed ID: 6127468
[No Abstract] [Full Text] [Related]
3. Biology of schizophrenia subtypes: a review and proposal for method of study.
Meltzer HY
Schizophr Bull; 1979; 5(3):460-79. PubMed ID: 39334
[No Abstract] [Full Text] [Related]
4. Schizophrenia: some current neurochemical approaches.
Rodnight R
J Neurochem; 1983 Jul; 41(1):12-21. PubMed ID: 6345723
[No Abstract] [Full Text] [Related]
5. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
Anokhina IP; Gamaleia NB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
[No Abstract] [Full Text] [Related]
6. [The endorphin hypothesis of schizophrenia].
Słowik S
Psychiatr Pol; 1982; 16(1-2):91-9. PubMed ID: 6292978
[No Abstract] [Full Text] [Related]
7. Dopamine-receptor-stimulating autoantibodies: a possible cause of schizophrenia.
Knight JG
Lancet; 1982 Nov; 2(8307):1073-6. PubMed ID: 6127547
[TBL] [Abstract][Full Text] [Related]
8. Etiopathogenesis and treatment of psychosis.
Crow TJ; Harrington CA
Annu Rev Med; 1994; 45():219-34. PubMed ID: 7911014
[TBL] [Abstract][Full Text] [Related]
9. Effect of amphetamine on brain catecholamines, brain beta-endorphin, serum prolactin, catechol-O-methyltransferase and monoamine oxidase of various organs in the rat.
Agarwal DP; Hoo JJ; Tjaden A; Nishigaki I; Beckermann WJ; Pahnke V; Goedde HW
Arzneimittelforschung; 1985; 35(11):1639-42. PubMed ID: 2936351
[TBL] [Abstract][Full Text] [Related]
10. Genetic vulnerability to schizophrenia.
Murray RM; Reveley AM; McGuffin P
Psychiatr Clin North Am; 1986 Mar; 9(1):3-16. PubMed ID: 3515330
[TBL] [Abstract][Full Text] [Related]
11. [Modifications of cerebral amine metabolism in psychiatric illness].
Linkowski P; Mendlewicz J
Acta Psychiatr Belg; 1980; 80(5):559-73. PubMed ID: 6165224
[TBL] [Abstract][Full Text] [Related]
12. Markers in psychoses: studies from India.
Sethi BB; Dube S; Sharma M
J Psychiatr Res; 1984; 18(4):361-72. PubMed ID: 6210360
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenia at the crossroads: a blueprint for the 80s.
Zubin J; Steinhauer SR; Day R; van Kammen DP
Compr Psychiatry; 1985; 26(3):217-40. PubMed ID: 3888516
[No Abstract] [Full Text] [Related]
14. [Inadequacy of the monoamine oxidase system--the probable pathogenetic factor in schizophrenia (review)].
Kolpakov VG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1254-63. PubMed ID: 4278558
[No Abstract] [Full Text] [Related]
15. Schizophrenia: a review of diagnostic and biological issues. II. Biological issues.
Deutsch SI; Davis KL
Hosp Community Psychiatry; 1983 May; 34(5):423-37. PubMed ID: 6133830
[TBL] [Abstract][Full Text] [Related]
16. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
Berger PA
J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
[TBL] [Abstract][Full Text] [Related]
17. [Biological markers in schizophrenia].
Lembreghts M; Ansseau M
Encephale; 1993; 19(5):501-23. PubMed ID: 8306920
[TBL] [Abstract][Full Text] [Related]
18. [Etiology of schizophrenia: neurochemical aspects].
de las Cuevas Castresana C; González de Rivera JL
Neurologia; 1994 Feb; 9(2):54-9. PubMed ID: 7515627
[No Abstract] [Full Text] [Related]
19. [Neurotransmitters and neuropeptides in schizophrenia].
Toru M; Ichikawa H
Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1838-54. PubMed ID: 6085408
[No Abstract] [Full Text] [Related]
20. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
Andreou D; Söderman E; Axelsson T; Sedvall GC; Terenius L; Agartz I; Jönsson EG
Psychiatry Res; 2015 Sep; 229(1-2):497-504. PubMed ID: 26142836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
